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 Abstract  
Background 
In critically ill patients with significant pulmonary hypertension (PH) close perioperative 
cardiovascular monitoring is mandatory, considering increased morbidity and mortality in this 
patient group. Although the pulmonary artery catheter is still the standard for the diagnosis of 
PH, its use to monitor cardiac output (CO) in PH patients is decreasing as a result of increased 
morbidity and possible influence of tricuspid regurgitation on the measurements. However, 
continuous CO measurement methods have never been evaluated under PH regarding their 
agreement and trending ability. The aim of this study was to evaluate the influence of acute 
PH and different CO states on transpulmonary thermodilution (TPTD) and calibrated pulse 
contour analysis (PiCCO; both assessed with PiCCOplusTM), intermittent (PATD) and 
continuous (CCO) pulmonary artery thermodilution as compared to a modified Fick method 
(FICK) in an animal model.  
Methods Nine healthy pigs were studied under anesthesia. Pulmonary hypertension of 25 and 
40 mmHg (by administration of the thromboxane analogue U46619), CO de- and increases 
were induced to test the different CO measurement techniques over a broad range of 
hemodynamic situations. Before each step a new baseline data set was collected. CO values 
were compared using Bland-Altman analysis; trending abilities were assessed using 
concordance and polar plot analysis. The influence of pulmonary pressure on CO 
measurements was analyzed using linear mixed models.  
Results A mean bias of -0.26 L/min with prediction intervals of -0.88 to 1.4 L/min were 
measured between TPTD and FICK. Their concordance rate was 100% (94-100%)(confidence 
interval) and the mean polar angle -3° with radial limits of agreement (RLOA) of ± 28° 
indicated good trending abilities. PATD compared to FICK also showed good trending 
ability. Comparisons of PICCO and CCO vs. FICK revealed low agreement and poor trending 
results with concordance rates of 84% (71-93%) and 88% (74-95%); mean polar angles from -
17° and -19° and RLOA of ± 45° and 40°. Pulmonary pressures influenced only the difference 
between FICK and PiCCO, as assessed by linear mixed models. 
Conclusion 
TPTD compared to FICK was able to track all changes induced during the study period 
including those by PH. It yielded better agreement than PATD both compared to FICK. 
PiCCO and CCO were not mapping all changes correctly and when used clinically in unstable 
patients, regular controls with intermittent techniques are required. Acute pharmacologically 
induced PH did influence the difference between FICK and PiCCO. 
 Introduction  
Patients with pulmonary hypertension (PH) have an increased morbidity and mortality in the 
perioperative setting of both cardiac and non-cardiac surgery.1-3 Although close monitoring of 
cardiovascular function is mandatory in patients with PH4 the perioperative use of the 
pulmonary artery catheter has been questioned as a result of an increased risk of arrhythmias 
and vessel ruptures in this patient group.5, 6 Furthermore, pulmonary artery thermodilution 
(PATD) cardiac output (CO) measurements may be distorted by tricuspid regurgitation.7 The 
severity of PH does not predict mortality, but measuring CO repeatedly and assessing the 
function of the right heart is an important prognostic factor and a measure of therapeutic 
success.4 
Transpulmonary thermodilution (TPTD) may be a valuable alternative to PATD for CO 
measurements in the setting of PH and may overcome some problems related to PATD in PH.  
Using TPTD the PATD catheter is replaced typically by a femoral or long radial artery 
thermodilution catheter.8 A cold fluid bolus is injected in the jugular vein or the right atrium 
by means of a central venous catheter. The temperature change following cold fluid 
administration is not detected in the pulmonary artery, but only after the fluid bolus has 
passed both sides of the heart and the lung in the central systemic circulation. Therefore, this 
CO measurement method is called “transpulmonary”. It is used in the PiCCOplus monitoring 
system to calibrate the continuous pulse contour analysis (PiCCO). Thus, this system can be 
used at the bedside to assess CO.  
However, TPTD and PiCCO have never been compared to a reference technique under 
increased pulmonary pressure conditions and their accuracy and trending ability in this setting 
is not known. Differences between methods can be induced through bias, different variability 
or different susceptibility to extraneous factors9 like changes of systemic or pulmonary 
arterial pressures. For clinical CO monitoring however, the accurate mapping of changes over 
time may be more important than the absolute CO value per se, in order to detect 
hemodynamic instability or to assess results of therapeutic measures.10, 11  
Continuous pulmonary artery thermodilution (CCO) measures CO with a modified pulmonary 
artery catheter equipped with a thermal coil, which is positioned in the right ventricle. The 
coil generates heat pulses and by repeatedly doing so the CO computer can construct a 
thermodilution washout curve and estimate CO automatically. The method has been evaluated 
in many studies with good agreement for slow hemodynamic changes, but during fast changes 
a time delay from 5 to 20 minutes to track changes has been reported.12 
 The aim of this study evaluate the influence of acute PH and different CO states on CO 
measurements by TPTD, PiCCO, PATD and CCO as compared to a modified Fick method 
(FICK) in an animal model. The hypothesis was, that changes in lung perfusion would 
influence TPTD and PiCCO less than PATD and continuous CO assessment by 
thermodilution (CCO) using the pulmonary artery catheter. 
 
Methods  
General 
This study was approved by the Cantonal Veterinary Office of Zurich (176/2011). Nine 
healthy landrace pigs aged 62 ± 1 day (mean ± standard deviation (SD)), weighing 25.7 ± 1.9 
kg were studied. The sample size of ten pigs was chosen on the basis of previous studies 
investigating agreement between CO methods in animal models.13,14 Only 9 pigs were 
included in the current study due to missing FICK CO data in one pig.  
The pigs were premedicated with midazolam 1 mg/kg (Dormicum, Roche Pharma, 
Switzerland) and ketamine 15 mg/kg (Narketan, Vetoquinol, Switzerland) intramuscularly. 
Anesthesia was induced with propofol (Propofol, Fresenius Kabi, Switzerland) and 
maintained with midazolam 0.5 mg/kg/h, propofol 4 mg/kg/h, fentanyl 20 µg/kg/h (Sintenyl, 
Sintetica SA, Switzerland) and pancuronium 0.2 mg/kg/h (Pavulon, Essex Chemie AG, 
Switzerland). Ringers lactate solution at a rate of 3 mL/kg/h (Ringer Laktat, Fresenius Kabi, 
Switzerland) was infused during the experiment and temperature was kept constant at 38.5 ± 
0.3°C by means of a forced-air warming blanket (Bair Hugger, Carbamed AG, Liebefeld, 
Switzerland). 
After endotracheal intubation the pigs were placed in dorsal recumbency and mechanical 
ventilation (S/5 Advance Anesthesia Machine, Datex-Ohmeda Inc., Madison, WI) was started 
using a volume controlled mode with the following settings: tidal volume of 6 mL/kg, 
positive end-expiratory pressure level of 7 cmH2O, inspiratory-to-expiratory ratio of 1:1 and 
FiO2 of 0.5. Respiratory rate was adjusted to keep the end-tidal partial pressure of CO2 at 40 ± 
3 mmHg.  
 
Instrumentation 
A 20 G catheter was placed in the carotid artery for blood gas sampling. A 7.5 Fr CCO 
pulmonary artery catheter (Swan-Ganz TD Catheter, Edwards Lifesciences 
AG, Switzerland) was placed via an 8.5 Fr introducer in the right internal jugular vein using 
 pressure guidance. A 4 Fr (22 cm) thermistor tipped femoral artery catheter (Pulsiocath 
PVPK2014L22-A, Pulsion Medical Systems, Munich, Germany) was introduced into the right 
femoral artery. An additional catheter was placed in the right atrium via the right jugular vein 
for administration of U46619. All catheters were inserted by means of a surgical cut-down. 
Standard three-lead electrocardiography, pulse oximetry, blood temperature, right atrial, 
pulmonary and peripheral arterial pressures were displayed using a multiparameter monitor 
(GE BL850, Anandic Medical Systems AG, Switzerland). Bispectral index (Bispectral Index 
Monitor, Model A-2000, Aspect Medical System, Inc., Newton, MA) was applied for 
monitoring and adjustment of depth of anesthesia in pigs as described before.15 Expired CO2 
analysis was performed with a mainstream CO2 infrared analyzer (NICO2, Respironics Inc., 
Murrysville, Pennsylvania). Mixed venous and arterial blood samples were taken before each 
CO measurement and blood gases as well as hemoglobin were immediately measured using a 
co-oximeter (GEM 4000, IL, Axon Lab, Switzerland).  
 
Cardiac Output Measurements 
To assess CO with a modified Fick method (FICK), the CO2 production per minute was 
calculated from the area under the curve of the capnogram during in- and expiration 
multiplied with the respiratory rate.16 The CO2 production was divided by a respiratory 
quotient of 0.8 to receive O2 consumption. This value was divided by the arterio-venous O2 
content difference to receive FICK CO values. Fick	   measurement	   was	   chosen	   as	   the	  reference	  method	  to	  exclude	  a	  potential	  influence	  of	  PH	  or	  tricuspid	  regurgitation	  that	  is	  reported	  for	  thermodilution	  methods. 
Each intermittent thermodilution measurement consisted of four fluid boluses of 10 mL ice-
cold 5% dextrose manually injected by the same operator into the proximal port of the 
pulmonary artery catheter located in the right atrium. Fluid bolus temperature was detected by 
two serial in-line sensors of the two cardiac output computers (PATD: Vigilance I, Edwards 
Lifesciences AG, Switzerland and TPTD: PiCCO Plus™, software version 6.0, Pulsion 
Medical Systems, Munich, Germany). The temperature changes in the pulmonary artery and 
in the distal abdominal aorta were simultaneously recorded with the two thermistor-tipped 
catheters and CO was calculated based on the Stewart-Hamilton equation by the 
corresponding CO computer. All thermodilution curves were visually controlled for regular 
shape. The mean of three thermodilution measurements within a variation of 10% was used to 
 calculate PATDmean and the 3 corresponding TPTD to calculate TPTDmean, which were used 
for statistical analysis.  
The PiCCOplus monitor automatically calibrates the pulse contour measurement PiCCO after 
every new set of TPTD bolus measurements. This calibration was allowed at each baseline 
measurement. During the step measurement, the automatic recalibration was not allowed. To 
prevent this calibration, the TPTD bolus measurements obtained during the steps were 
manually deleted in the monitors’ memory. This enabled us to analyze the trending ability 
over each intervention step (PH25, PH40, COup and COdown) over a one-hour period.  
In order to avoid influence of the cold injectate, continuous PiCCO and CCO values were 
recorded directly before a new set of bolus measurements was performed. Pulmonary artery 
wedge pressures were measured after CO measurements by occluding the pulmonary artery 
with the balloon on the tip of the pulmonary artery catheter. If the artery could not be 
occluded during the step PH25 or PH40 due to dilation of the vessel, no repositioning of the 
catheter was attempted to avoid interference with concurrent dead space measurements 
performed for another study in the same pigs.14 We report the global ejection fraction (GEF) 
as it is calculated by the PiCCOplus monitor: GEF [mL] = stroke volume / (GEDV / 4). 
GEDV is assessed from the transpulmonary thermodilution curve: CO * (mean transit time – 
exponential downslope time). GEDV and GEF assessments have been described in detail.17 
 
Study protocol  
In order to assess the influence of changes of pulmonary and systemic pressures and the 
performance of different cardiac output measurement methods four individual steps were 
defined (Figure 1). Two levels of pulmonary hypertension - i.e. PH25 (mean pulmonary artery 
pressure of 25 mmHg) and PH40 (mean pulmonary artery pressure of 40 mmHg) - were 
induced by infusing 2 µg/kg/min U46619, a thromboxane analogue, into the right atrium. The 
rate was increased or decreased in order to reach a stable target pressure of either a mean 
pulmonary artery pressure of 25 mmHg or 40 mmHg. To increase pulmonary pressures by 
rising lung perfusion CO was increased by 50% from baseline (COup) by administration of 30 
mL/kg Ringers lactate and dobutamine (Dobutrex, Teva Pharma AG, Switzerland) at an initial 
dose of 5 µg/kg/min. The dose of dobutamine was adapted in order to reach the target CO 
value. CO was decreased by 40% from baseline (COdown) by sodium nitroglycerine infusion 
30 µg/kg/min (Perlinganit, UCB Pharma AG, Switzerland) and esmolol 500 µg/kg/min 
(Esmolol OrPha Swiss GmbH, Switzerland). All steps were performed in random order in an 
 individual pig. Baseline data were obtained before each protocol step. CO measurements were 
started after reaching stable conditions for 5 minutes of the predefined pressure or CO values. 
At least 30 minutes were allowed between steps and the next step was initiated when 
cardiovascular parameters were within 5% of the baseline values. At the completion of the 
experiment the pigs were sacrificed by intravenous administration of pentobarbital 
(Esconarkon, Streuli AG, Switzerland).  
 
Figure 1 Study protocol 
PH25 and PH40: pulmonary hypertension 25 mmHg and 40 mmHg, COdown: cardiac output decrease and COup: increase; RL: 
Ringer’s Lactate solution, U 46619: thromboxane analogue, FICK: modified Fick method, PiCCO: pulse contour analysis 
with PiCCOplusTM, CCO: continuous thermodilution, PATD: pulmonary artery and TPTD: transpulmonary thermodilution, 
PAWP: pulmonary artery wedge pressure 
 
 
Statistical analysis 
Cardiovascular changes were analyzed by paired t-tests. Comparison of absolute CO values 
measured by the different techniques was performed by linear mixed effects models and by 
Bland-Altman analysis. To adjust for the small sample size the t-statistic for 9 pigs was 
calculated: !!.!"#(!!!)  ×   1+ 1/9  = 2.431. To calculate the prediction intervals (limits of 
agreement) 2.431  was multiplied with the SD of the mean bias. The commonly used value of 
1.96 can be used in studies with n ≥ 60. Mean percentage error was calculated as 100 x 2.431 
x SD of the mean bias / mean CO of both methods to make the results comparable to former 
studies and between steps.18 
For the comparison of trending capabilities of the different techniques changes of CO (Δ CO) 
were calculated for each set of measurements and concordance and polar plots were done as 
 recently described by Critchley et al.,10, 11 setting the exclusion zone at CO changes of ≤ 10% 
(polar plot) and ≤15% (concordance). To calculate the confidence interval (CI) of the 
concordance rate generalized mixed effects models with pig as random effect and an intercept 
were fitted. The exponential of the beta coefficient of the intercept (± 2 x standard error) 
corresponds to the odds (95% CI of odds). The odds -being equal to π/1- π- were solved for π 
(and the corresponding lower and upper limits). 
Linear mixed effects models were also used to assess if a potential association between mean 
arterial or mean pulmonary artery blood pressure and the measured CO values was influenced 
by the method (interaction effect between method and mean arterial or mean pulmonary artery 
blood pressure). Utilizing the triplicate measurements, linear mixed effects models were 
applied to test the difference of the variability of PATD and TPTD. Model selection (e.g. 
deciding which of the explanatory variables - mean arterial blood pressure, mean pulmonary 
artery blood pressure, effect of CO method or an interaction term - should be included in the 
final model) was based on Akaike information criteria, which is a goodness-of-fit criterion 
model that allows a qualitative assessment of the variables with lower values indicating a 
better model fit.19 Data management was done using Excel for Macintosh (Office X, 
Microsoft, Redmond, WA). Graphs were performed with Prism 6.0f (GraphPad Software, San 
Diego,CA) and SigmaPlot 10.0 (Systat Software, San Jose, CA). Linear mixed models and 
Bland-Altman calculations with repeated measures were performed with R20 and the packages 
nlme21 and MethComp.22  
 
Results  
Hemodynamic data during the study period are displayed in Table 1. All techniques (FICK, 
PATD, CCO, TPTD, PiCCO) detected the significant CO reduction (all p < 0.039) and CO 
increase (all p < 0.016) during step COdown and COup, respectively. Drug induced pulmonary 
hypertension of 25 mmHg did not result in significant changes in CO assessed by any of the 
used methods (all p > 0.134), while PH 40 mmHg induced a significant decrease in CO in all 
methods (all p < 0.025) but CCO (p = 0.236).  
  
 Table 1. Hemodynamic changes during the study period 
Table 1: General hemodynamic results of nine pigs during 4 steps: pulmonary hypertension 25 mmHg (PH25) and 40 mmHg 
(PH40), cardiac output decrease (COdown) and increase (COup). Values are presented as mean ± standard deviation. Modified 
Fick (FICK), Pulmonary artery (PATD) and transpulmonary thermodilution (TPTD), pulse contour analysis (PiCCO), 
continuous thermodilution (CCO), heart rate (HR), mean arterial blood pressure (MAP), central venous pressure (CVP), 
systemic vascular resistance (SVR = MAP-CVP * 80 / COFick), mean pulmonary arterial pressure (MPAP), pulmonary 
artery wedge pressure (PAWP),global ejection fraction (GEF = stroke volume / (global end-diastolic volume / 4)), 
Temperature (T). Statistical significance (p<0.05) between BL and step is marked with ★ and p values marked. The data was 
tested with paired t-tests.  
  
  
PH25 PH40 COdown COup 
BL Step BL Step BL Step BL Step 
FICK 
(L/min) 
3.7 
±0.5 
 
3.7 
±0.6 
p = 0.67   
4.1 
±0.9 
★3.2 
±0.5 
p =  0.002 
3.9 
±0.6 
★2.3 
±0.3 
p < 0.0001 
3.7 
±0.5 
★6.7 
±0.8 
p < 0.0001 
PATD 
(L/min) 
3.2 
±0.5 
3.0 
±0.3 
p = 0.14 
3.4 
±0.6 
★2.8 
±0.3 
p = 0.001 
3.1 
±0.5 
★1.9 
±0.5 
p = 0.001 
3.1 
±0.5 
★5.5 
±0.7 
p < 0.0001 
TPTD 
(L/min) 
3.6 
±0.5 
3.5 
±0.5 
p = 0.61 
3.8 
±0.5 
★3.1 
±0.4 
p = 0.0004 
3.5 
±0.5 
 
★2.4 
±0.2 
p = 0.0001 
3.5 
±0.4 
★5.7 
±0.7 
p < 0.0001 
PiCCO 
(L/min) 
3.7 
±0.6 
3.3 
±0.6 
p = 0.13  
3.8 
±0.7 
★3.3 
±0.4 
p = 0.025 
3.6 
±0.6 
★2.8 
±0.6 
p = 0.04 
3.6 
±0.5 
★4.3 
±0.6 
p = 0.02 
CCO 
(L/min) 
4.5 
±1.1 
4.3 
±0.8 
p = 0.29  
4.5 
±1.1 
4.3 
0.9 
p = 0.24 
4.2 
±0.9 
★3.4 
±0.9 
p = 0.0007 
4.1 
±0.9 
★5.1 
±0.8 
p =0.007 
HR 
(1/min) 
106 
±6 
103 
±7 
113 
±9 
114 
±11 
107 
±6 
108 
±15 
111 
±10 
120 
±14 
MAP 
(mmHg) 
79 
±10 
★87 
±11 
p = 0.002 
80 
±11 
87 
±13 
p = 0.15 
80 
±10 
★33 
±5 
p < 0.0001 
77 
±11 
★112 
±14 
p < 0.0001 
CVP 
(mmHg) 
5 
±2 
6 
±3 
p = 0.1  
5 
±2 
★7 
±1 
p = 0.0002 
6 
±2 
5 
±2 
p = 0.1 
6 
±2 
★8 
±2 
p = 0.007 
SVR 
(dyn•sec/cm5) 
1590 
±240 
★1777 
±314 
p = 0.02 
1497 
±308 
★2097 
±558 
p = 0.001 
1581 
±303 
★971 
±200 
p = 0.0008 
1558 
±260 
★1248 
±144 
p = 0.002 
MPAP 
(mmHg) 
17 
±1 
★25 
±1 
p < 0.0001 
17 
±2 
★41 
±3  
p < 0.0001 
17 
±1 
★14 
±2 
p = 0.0002 
17 
±1 
★21 
±2 
p = 0.0001 
PAWP 
(mmHg) 
5 
±1 
5 
±0.7 
p = 0.6 
6 
±1 
6 
(n=1) 
6 
±1 
6 
±2 
p = 0.27 
6 
±1 
★7 
±2 
p = 0.03 
GEF 
(%) 
34 
±3 
★31 
±2 
p = 0.01 
34 
±4 
★26 
±2 
p < 0.0001 
33 
±3 
★24 
±5 
p = 0.0007 
33 
±3 
★42 
±4 
p < 0.0001 
T 
(°C) 
38.5 
±0.3 
38.7 
±0.4 
38.7 
±0.3 
38.7 
0.2 
38.7 
±0.3 
38.5 
±0.2 
38.6 
±0.2 
38.1 
±0.2 
 Linear mixed model and Bland-Altman results (Figures 2 a-d) and percentage errors 
calculated for each step are presented in Table 2.  
 
 
 
 
 
 
 
 
 
Figure 2 Bland Altman plots for multiple comparisons per individual with the difference between the methods plotted 
against their mean 
a) FICK vs PATD  
b) FICK vs TPTD 
c) FICK vs PiCCO 
d) FICK vs CCO 
Footnote: FICK: modified Fick method, PATD: pulmonary artery thermodilution, TPTD: transpulmonary thermodilution, 
PiCCO: pulse contour analysis with PiCCOplusTM, CCO: continuous thermodilution. The solid line represents the mean bias, 
the two broken lines the prediction intervals (bias ± 2.431 standard deviation); the dotted line is the line of equality.  
 
  
2a 2b 
2c 2d 
 Table 2. Bland-Altman results 
  Method 1 Fick PATD TPTD PiCCO 
  Method 2 PATD TPTD PiCCO CCO TPTD PiCCO CCO PiCCO CCO CCO 
All 
n 72 71 70 55 71 70 55 69 54 54 
Mean bias (L/min) 0.64 0.26 0.38 -0.26 -0.37 -0.26 -0.95 0.12 -0.52 -0.67 
SD (L/min)  0.50 0.47 0.93 1.14 0.23 0.73 0.87 0.69 0.93 0.83 
Lower PI (L/min) -0.58 -0.88 -1.88 -3.03 -0.93 -2.03 -3.06 -1.56 -2.78 -2.69 
Upper PI (L/min) 1.86 1.40 2.64 2.51 0.19 1.51 1.16 1.80 1.74 1.35 
Percentage error (%) 34 30 61 67 16 52 55 46 56 51 
BL 
n 36 36 36 28 36 36 45 36 28 28 
Mean bias (L/min) 0.62 0.24 0.21 -0.36 -0.39 -0.42 -1.02 -0.03 -0.61 -0.55 
SD (L/min) 0.39 0.35 0.38 0.76 0.19 0.37 0.62 0.35 0.74 0.76 
Lower PI (L/min) -0.33 -0.61 -0.71 -2.21 -0.85 -1.32 -2.53 -0.88 -2.41 -2.40 
Upper PI (L/min) 1.57 1.09 1.13 1.49 0.07 0.48 0.49 0.82 1.19 1.30 
Percentage error (%) 27 23 25 44 14 26 40 23 45 45 
PH 25 
n   9 9 9 7 9 9 7 9 7 7 
Mean bias (L/min) 0.65 0.87 0.35 -0.51 -0.47 -0.31 -1.24 0.16 -0.69 -0.86 
SD (L/min) 0.46 0.39 0.40 0.85 0.27 0.38 0.59 0.36 0.79 0.72 
Lower PI (L/min) -0.47 -0.08 -0.62 -2.58 -1.13 -1.23 -2.67 -0.72 -2.61 -2.61 
Upper PI (L/min) 1.77 1.82 1.32 1.56 0.19 0.61 0.19 1.04 1.23 0.89 
Percentage error (%) 33 26 28 52 20 29 42 26 52 45 
PH 40 
n   9 9 7 6 9 7 6 7 6 6 
Mean bias (L/min) 0.34 0.01 0.08 -1.08 -0.33 -0.43 -1.37 -0.18 -1.07 -1.11 
SD (L/min) 0.27 0.32 0.50 0.75 0.22 0.32 0.78 0.27 0.97 0.90 
Lower PI (L/min) -0.32 -0.77 -1.14 -2.90 -0.86 -1.21 -3.27 -0.84 -3.43 -3.30 
Upper PI (L/min) 1.00 0.79 1.30 0.74 0.20 0.35 0.53 0.48 1.29 1.08 
Percentage error (%) 22 25 37 53 18 25 53 20 64 62 
CO 
down 
n   9 8 9 7 8 9 7 8 6 7 
Mean bias (L/min) 0.40 -0.01 -0.48 -1.07 -0.32 -0.88 -1.51 -0.51 -1.01 -0.76 
SD (L/min) 0.35 0.26 0.48 0.90 0.18 0.56 0.86 0.59 0.85 1.07 
Lower PI (L/min) -0.45 -0.64 -1.65 -3.26 -0.76 -2.24 -3.60 -1.94 -3.08 -3.36 
Upper PI (L/min) 1.25 0.62 0.69 1.12 0.12 0.48 0.58 0.92 1.06 1.84 
Percentage error (%) 41 27 46 78 20 59 86 55 71 87 
CO up 
n   9 9 9 7 9 9 7 9 7 7 
Mean bias (L/min) 1.22 0.94 2.41 1.81 -0.28 1.19 0.49 1.46 0.84 -0.66 
SD (L/min) 0.78 0.58 0.77 0.69 0.31 0.70 0.61 0.61 0.60 0.92 
Lower PI (L/min) -0.68 -0.47 0.54 0.13 -1.03 -0.51 -0.99 -0.02 -0.62 -2.90 
Upper PI (L/min) 3.12 2.35 4.28 3.49 0.47 2.89 1.97 2.94 2.30 1.58 
Percentage error (%) 31 23 34 28 13 35 30 30 28 47 
Bland-Altman cardiac output (CO) results for multiple measurements per subject of 9 pigs measured with Modified Fick 
(FICK), pulmonary artery (PATD) and transpulmonary thermodilution (TPTD), pulse contour analysis (PiCCO) and 
continuous thermodilution (CCO). 
All: all measurements pooled, BL: all baselines pooled, PH 25 and PH 40: pulmonary hypertension 25 mmHg and 40 mmHg, 
COdown: CO decrease and COup : CO increase.Values are presented as mean bias, SD: standard deviation, lower and 
upper PI: 95% prediction intervals (= mean bias ± 2.431 SD), percentage error = 100 x 2.431 x SD / mean CO of 
both methods. 
 The TPTD bolus method showed good trending ability compared to FICK and PATD with a 
concordance rate of 100% with 95% CI of 94 to 100%. The concordance rate of PATD 
against FICK was 96% (87-100%). Both continuous methods showed limited trending 
abilities with concordance rates below 90% (Table 3 and Figures 3a-d).  
 
Table 3 Trending results 
Method 1 FICK PATD TPTD PiCCO  
Method 2 PATD TPTD PiCCO CCO TPTD PiCCO CCO PiCCO CCO CCO 
Exclusion zone ≤15% 
Data points 71 70 67 54 70 66 54 66 52 52 
> 15 % change 52 50 45 42 50 50 42 49 40 39 
Wrong quarter  2 0 7 5 0 7 5 7 6 6 
Concordance rate  96% 100% 84% 88% 100% 86% 88% 86% 85% 85% 
Confidence 
interval (%) 
*87-
100% 
*93-
100% 
71-  
92% 
74-   
95% 
*94-
100% 
69-  
94% 
67-  
98% 
69-   
94% 
65-  
96% 
70-    
93% 
Exclusion zone ≤10% 
Mean polar angle -2° -3° -17° -19° -1° -19° -17° -14° -15° -2° 
Standard deviation  14° 11° 22° 22° 8° 25° 19° 25° 20° 27° 
Radial limits of 
agreement  28° 28° 45° 40° 16° 50° 30° 48° 41° 43° 
Concordance and polar plot results of 9 pigs measured with modified Fick (FICK), pulmonary artery (PATD) and 
transpulmonary thermodilution (TPTD), pulse contour analysis (PiCCO) and continuous thermodilution (CCO). Exclusion 
zones were set at ≤10 (polar plot) and ≤15% (concordance) change of CO. 
Values are presented as concordance rate (> 15% change – wrong quarter) / > 15% change with 95% confidence intervals 
(*due to non-convergence of the models, binomial confidence intervals are presented), mean polar angle, standard deviation 
and radial limits of agreement (95% of data points).  
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Figure 3 Concordance and polar plots of percentage change that compare trending abilities between 5 methods of 
cardiac output measurement 
a) FICK vs PATD  
b) FICK vs TPTD 
c) FICK vs PiCCO 
d) FICK vs CCO 
 
Footnote: FICK: modified Fick method, PATD: pulmonary artery thermodilution, TPTD: transpulmonary thermodilution, 
PiCCO: pulse contour analysis with PiCCOplusTM, CCO: continuous thermodilution.  
In the concordance plot the dotted lines limit an exclusion zone of 15%. Values within this zone are shown in grey. Black 
dots in the left upper and right lower quadrant but outside of the central grey 15% zone are signs for inadequate trending of 
CO changes.  
Half circle polar plots are shown with data transformed to positive directional data only, the distance from the center 
represents the mean change in cardiac output (ΔCO) and the angle θ  with the horizontal axis depicts the agreement of the 
methods. Data points outside a 30° from the 0° horizontal axis are a sign for inadequate trending. Data points with mean 
changes ≤ 10% were excluded from the analysis and are shown as open circles. Solid line: mean polar angle; dotted lines: 
radial limits of agreement. 
 
Mean pulmonary artery blood pressure did influence the difference between FICK and PiCCO 
measurements as assessed by linear mixed effects models. The differences between FICK and 
PATD, TPTD and CCO respectively were not influenced by mean pulmonary artery blood 
pressure. Both mean arterial and mean pulmonary artery blood pressure, were influenced by 
the steps (interaction effect between mean arterial and mean pulmonary artery blood pressure 
and steps). Based on Akaike information criteria, there was no evidence that the triplicate 
measurements with PATD and TPTD differed in their variability.  
 
Discussion 
In this study the influence of two degrees of acute PH and CO de- and increases on the 
accuracy and the trending ability of four CO methods compared to FICK were assessed in 
nine pigs. Both intermittent methods TPTD and PATD yielded good trending ability 
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 compared to FICK. The bolus method TPTD showed better agreement than PATD with FICK 
CO measurements. Both continuous CO measurement methods - PiCCO and CCO - showed 
poor accuracy and limited trending ability as compared with FICK. No influence of 
pulmonary artery pressure on the difference between all thermodilution methods PATD, 
TPTD and CCO was revealed by linear mixed models. Only the difference between FICK and 
the pulse contour analysis PiCCO was influenced by pulmonary artery pressure.  
 
The results of this study regarding TPTD are in agreement with a variety of other studies 
evaluating the performance of TPTD. These previous studies assessed CO by TPTD against 
PATD under different clinical conditions but none of them involved PH. Based on the present 
favorable results it can be argued that TPTD can reliably be used for CO measurements as an 
alternative to PATD avoiding a pulmonary artery catheter. Although adequate accuracy of CO 
measurement by thermodilution techniques in PH patients23 or animal models of tricuspid 
regurgitation have been reported,24 it has - unfortunately - to be emphasized that 
thermodilution may under- or overestimate CO due to inadequate mixing or loss of indicator 
when PH and tricuspid regurgitation develop.7, 25 Therefore, the Fick method has still to be 
considered the standard of CO measurement under these specific clinical conditions.4 The 
current data suggests better agreement and trending ability of TPTD than of PATD when 
compared to FICK. Considering technical aspects of these techniques, PATD (measurement 
in the right heart) may be more influenced than TPTD (measurement of the total vascular bed 
from right atrium to the left ventricular outflow) by changing pulmonary pressures. 
All pulse contour methods have been shown to be susceptible to changes in peripheral 
vascular resistance.13,26-28 The calibrated methods have the advantage that they can be 
recalibrated in order to better reflect any acute changes of vascular tone. The present study 
protocol involved major induction of hemodynamic changes and vasoactive drug application. 
As a result inferior agreement of PiCCO and FICK measurements was observed despite 
recalibration before any next hemodynamic change was performed. Still, other studies 
observed a comparable PiCCO performance without the influence of PH.11 The trending 
ability of PiCCO against FICK with concordance rates between 80% and 90% and polar plot 
results (radial limits of agreement of 45°) confirm these results. However, the applied linear 
mixed models did reveal an influence of mean pulmonary artery pressure on the difference 
between PiCCO and FICK measurements, opposed to no influence on all thermodilution 
measurement. This finding is unexpected and cannot be explained with the other findings of 
the current study. The device may still be used in its’ continuous mode when elevated 
 pulmonary artery pressures are present, considering the requirement of frequent recalibration 
in order to guarantee acceptable CO measurement results under unstable hemodynamic 
conditions.13,27 
The PiCCO system combining TPTD and the pulse contour method PiCCO allows the 
additional assessment of different volumetric and functional hemodynamic parameters. These 
parameters may help to early detect hemodynamic instability and to initiate prompt and 
appropriate hemodynamic therapy. During PH the right ventricle is dilated and can eject less 
flow through the lung vessels to the left ventricle. This seems to be correctly reflected by 
TPTD, as the left ventricle cannot deliver more flow than it receives from the right side. The 
concept ‘pulmonary flow equals systemic flow’ applies in this setting even if acute increases 
in mean pulmonary artery pressure may influence the cardiac work of the ventricles 
differently. If a PH patient is monitored with TPTD and PiCCO no direct measurements of 
pulmonary artery pressures are possible. As the severity of PH does not predict mortality,4 it 
may be more important to correctly monitor cardiac function than measure exact pulmonary 
artery pressures with a pulmonary artery catheter. Echocardiography can be used to 
intermittently estimate pressures and assess the function of both ventricles. 
In the present study comparing CCO to FICK resulted in low agreement and a limited 
trending ability. In this acute setting CCO updates were apparently too slow to reliably track 
changes.12 In order to detect changes appropriately, the changes induced during and after the 
different hemodynamic steps would have to be stable for at least 10 to 20 minutes before each 
comparative hemodynamic assessment. High CCO values measured may be the result of a 
catheter-related problem. Clearly, the positions of the pulmonary artery catheter proximal and 
distal openings’ were verified using the detection of the typical pressure waveforms and the 
related changes during insertion. Still, the length of the heating wire might have been too long 
for these pigs that had a weight of 26 kg. However, linear mixed models indicate that PH does 
not influence the difference between CCO and FICK, and CCO measurements can probably 
be used in PH patients to monitor CO at the bedside considering a delay of up to 10 minutes12 
and the typical limitations of thermodilution methods under PH.  
Major limitations of the present study are primarily related to the animal model and the 
measurement techniques used during PH: 
Pharmacologically induced hypertension in animals with normal pulmonary vessels was used 
as a model for a variance of pathophysiological different diseases causing PH.29 Typically 
around 50% of the possible increase of pulmonary vascular resistance in PH patients is 
 mediated through reversible vasoconstriction,4 although individual variations of vascular 
involvement might be observed. Moreover, our model is not able to mimic vascular 
remodeling, thrombosis or congestion from the left atrium. It can only reflect pulmonary 
arterial hypertension with low left atrial pressure, i.e. the so-called pre-capillary PH.29 
Therefore, no conclusion regarding CO measurement performance in patients with different 
classes of PH having vascular remodeling or left ventricular impairment as result of a failing 
right heart can be made. 
Two bolus methods were assessed by analyzing the temperature changes induced by the same 
bolus of ice-cold fluid, a technique that should reduce the influence of temporal changes of 
CO and therefore decrease type I errors between the methods. Recalibration of PiCCO before 
each subsequent measurement period may also have reduced the error compared to longer 
calibration free periods. Another source of error may be the intravenous administration of 30 
mL/kg Ringers lactate in order to increase CO in a randomized order. Moreover, the 
comparison of a less invasive method with a reference method requiring a pulmonary artery 
catheter possibly increased tricuspid regurgitation along the catheter, which may lead to a 
further loss of indicator in the thermodilution methods. To avoid this, TPTD may be 
compared to a CO measurement method such as Doppler flow measurement. However, the 
placement of a flow probe around the pulmonary artery requires a thoracotomy, which was 
avoided in these animals due to concurrent studies.  
Fick measurement was chosen as the reference method to exclude a potential influence of PH 
or tricuspid regurgitation. We did not measure oxygen consumption during the study and 
therefore had to use a modified Fick method. We divided the measured CO2 production by a 
respiratory quotient of 0.8 to receive O2 consumption. This estimated respiratory quotient may 
have introduced a source of error that cannot be quantified in the current study.  
In the current study presence of tricuspid regurgitation or other valvular abnormalities was not 
quantified by transesophageal echocardiography.  
Our data suggests good trending ability of TPTD and PATD compared to FICK. TPTD 
yielded better results of agreement than PATD with FICK CO measurements. The trending 
abilities of the PiCCO and CCO were limited and when used clinically in unstable patients, 
regular controls with intermittent techniques are required. Acute pharmacologically induced 
PH did influence the difference between Fick and PiCCO. 
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